PCN47 COMPARISON OF HEALTH CARE RESOURCE UTILIZATION AND COSTS BETWEEN NILOTINIB AND DASATINIB AS SECOND LINE THERAPIES IN CHRONIC MYELOID LEUKEMIA (CML)

✍ Scribed by EQ Wu; V Bollu; A Guo; A Guerin; M Tsaneva; D Williams; JD Griffin

• Book ID: 118609821
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 77 KB
• Volume: 13
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)72136-7